biostudies-literatureUnknown6(2)Bock JM<h4>Objective</h4>To determine whether continuous positive airway pressure (CPAP) adherence reduces health care-related costs or use in patients with obstructive sleep apnea (OSA) and comorbid cardiovascular disease (CVD).<h4>Patients</h4>A total of 23 million patients with CVD were identified in the Medicare fee-for-service database. Of the 65,198 who completed a sleep study between January 2016 and September 2018, 55,125 were diagnosed as having OSA and 1758 were identified in the 5% Medicare durable medical equipment (DME) database.<h4>Methods</h4>Patients with DME claims were categorized as adherent (AD, treatment evidenced ≥91 days after CPAP initiation; n=614) or nonadherent (nAD, n=242) to CPAP therapy. In addition, 9881 individuals with CVD who were not diagnosed as having OSA afteMayo Clinic proceedings. Innovations, quality & outcomes166-175https://www.ebi.ac.uk/biostudies/studies/S-EPMC8987617biostudies-literatureContinuous Positive Airway Pressure Adherence and Treatment Cost in Patients With Obstructive Sleep Apnea and Cardiovascular Disease.PMC8987617Ekono MMLerman ABock JMGregory DAWickwire EMSomers VKNeedham KAfalseContinuous Positive Airway Pressure Adherence and Treatment Cost in Patients With Obstructive Sleep Apnea and Cardiovascular Disease.<h4>Objective</h4>To determine whether continuous positive airway pressure (CPAP) adherence reduces health care-related costs or use in patients with obstructive sleep apnea (OSA) and comorbid cardiovascular disease (CVD).<h4>Patients</h4>A total of 23 million patients with CVD were identified in the Medicare fee-for-service database. Of the 65,198 who completed a sleep study between January 2016 and September 2018, 55,125 were diagnosed as having OSA and 1758 were identified in the 5% Medicare durable medical equipment (DME) database.<h4>Methods</h4>Patients with DME claims were categorized as adherent (AD, treatment evidenced ≥91 days after CPAP initiation; n=614) or nonadherent (nAD, n=242) to CPAP therapy. In addition, 9881 individuals with CVD who were not diagnosed as having OSA afte2022-01-01T00:00:00Z2022 Apr2025-04-26T15:15:11.422Z2025-04-06T14:52:56.179ZS-EPMC89876173539958410.1016/j.mayocpiqo.2022.01.002